We first confirmed that RM1 cells expressed AR (Fig. 7C) and were growth inhibited by MeT and DHT (Fig. 7D; Supplementary Fig. S5A), which collectively highlight the suitability of this model as a tool to understand the impact of potent androgen treatment on prostate cancer biology. This evidence concerns the gene AR and prostate carcinoma.